All of the relevant financial relationships listed below have been mitigated.
Susan Gearhart, MD: This individual has no financial relationships with ineligible companies.
Vlad Simianu, MD, MPH: This individual has no relevant relationships with ineligible companies.
Learning Objectives:
Upon completion of this activity, participants should be able to:
Recognize the use of 3D image guidance for training both faculty and surgical residents in the planning and execution of complex minimally invasive colorectal procedures.
Demonstrate the current methods for real-time image-guided robotic surgery.
Describe how monoclonal antibody labeling technology can assist in intraoperative tumor identification.
CME Credit: 1 Contact Hours: 1
The advent of minimally invasive surgery represents the leading innovation in the modern colorectal surgery era. In addition, the advances in CR and MR imaging have revolutionized the diagnostic approach to the surgical management of many of the diseases colorectal surgeons encounter. Finally, advanced genomics has greatly affected our diagnostic and therapeutic abilities in cancer care. The future for this specialty is the merging of these technologies to provide precision medicine in the care of the complex conditions colorectal surgeons care for.
This symposium will introduce you to the current status of where we are with employing image guidance in surgery. Dr. Ghazi is a leader in the field of robotic simulation and has developed methods to use 3D VR imaging to train surgical residents in robotic urological surgery. Dr. Lubelski and his colleagues designed the first robot to provide real-time feedback with image guidance in Neurosurgery and serves to benefit colorectal surgery through complex cases requiring sacral amputation. Finally, Dr. De Wilt has completed a national Dutch trial examining CEA labeling with Fluorescence for improving negative resection margins in the setting of HIPEC and is preparing a clinical trial in rectal cancer.
